Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9643 |
High Similarity |
NPD548 |
Clinical (unspecified phase) |
0.9267 |
High Similarity |
NPD1776 |
Approved |
0.9267 |
High Similarity |
NPD1777 |
Approved |
0.8819 |
High Similarity |
NPD249 |
Approved |
0.8819 |
High Similarity |
NPD250 |
Approved |
0.8725 |
High Similarity |
NPD1369 |
Phase 2 |
0.8725 |
High Similarity |
NPD1750 |
Clinical (unspecified phase) |
0.8699 |
High Similarity |
NPD186 |
Discovery |
0.8699 |
High Similarity |
NPD195 |
Approved |
0.8681 |
High Similarity |
NPD185 |
Approved |
0.8562 |
High Similarity |
NPD166 |
Approved |
0.8553 |
High Similarity |
NPD2646 |
Discontinued |
0.8553 |
High Similarity |
NPD2624 |
Phase 2 |
0.8553 |
High Similarity |
NPD1732 |
Phase 3 |
0.8542 |
High Similarity |
NPD193 |
Suspended |
0.8477 |
Intermediate Similarity |
NPD3107 |
Discontinued |
0.8467 |
Intermediate Similarity |
NPD283 |
Approved |
0.8447 |
Intermediate Similarity |
NPD1412 |
Clinical (unspecified phase) |
0.8421 |
Intermediate Similarity |
NPD339 |
Approved |
0.8355 |
Intermediate Similarity |
NPD242 |
Approved |
0.8355 |
Intermediate Similarity |
NPD338 |
Approved |
0.8247 |
Intermediate Similarity |
NPD169 |
Phase 2 |
0.8214 |
Intermediate Similarity |
NPD2631 |
Clinical (unspecified phase) |
0.8214 |
Intermediate Similarity |
NPD2632 |
Approved |
0.8214 |
Intermediate Similarity |
NPD2630 |
Approved |
0.8169 |
Intermediate Similarity |
NPD248 |
Discontinued |
0.8095 |
Intermediate Similarity |
NPD6417 |
Clinical (unspecified phase) |
0.8028 |
Intermediate Similarity |
NPD870 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD214 |
Approved |
0.8 |
Intermediate Similarity |
NPD213 |
Clinical (unspecified phase) |
0.7962 |
Intermediate Similarity |
NPD218 |
Approved |
0.7962 |
Intermediate Similarity |
NPD217 |
Approved |
0.7962 |
Intermediate Similarity |
NPD220 |
Clinical (unspecified phase) |
0.7962 |
Intermediate Similarity |
NPD216 |
Approved |
0.7962 |
Intermediate Similarity |
NPD219 |
Phase 3 |
0.7901 |
Intermediate Similarity |
NPD2647 |
Phase 3 |
0.773 |
Intermediate Similarity |
NPD7988 |
Suspended |
0.7665 |
Intermediate Similarity |
NPD5666 |
Phase 2 |
0.7625 |
Intermediate Similarity |
NPD546 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD247 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD4171 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD4716 |
Approved |
0.7473 |
Intermediate Similarity |
NPD4495 |
Phase 1 |
0.7442 |
Intermediate Similarity |
NPD4744 |
Clinical (unspecified phase) |
0.7439 |
Intermediate Similarity |
NPD3083 |
Approved |
0.7432 |
Intermediate Similarity |
NPD9632 |
Phase 3 |
0.7378 |
Intermediate Similarity |
NPD516 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD7158 |
Phase 1 |
0.7365 |
Intermediate Similarity |
NPD9633 |
Phase 3 |
0.7356 |
Intermediate Similarity |
NPD1692 |
Approved |
0.7303 |
Intermediate Similarity |
NPD252 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD9408 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD5684 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD5682 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD5683 |
Clinical (unspecified phase) |
0.725 |
Intermediate Similarity |
NPD3708 |
Phase 2 |
0.7237 |
Intermediate Similarity |
NPD194 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD231 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD582 |
Approved |
0.7115 |
Intermediate Similarity |
NPD549 |
Approved |
0.7095 |
Intermediate Similarity |
NPD207 |
Discontinued |
0.7055 |
Intermediate Similarity |
NPD536 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD7138 |
Phase 2 |
0.6899 |
Remote Similarity |
NPD3695 |
Approved |
0.6899 |
Remote Similarity |
NPD3696 |
Approved |
0.6839 |
Remote Similarity |
NPD209 |
Clinical (unspecified phase) |
0.6829 |
Remote Similarity |
NPD3085 |
Phase 1 |
0.6803 |
Remote Similarity |
NPD9606 |
Approved |
0.6788 |
Remote Similarity |
NPD3086 |
Phase 3 |
0.6757 |
Remote Similarity |
NPD9607 |
Approved |
0.6754 |
Remote Similarity |
NPD2965 |
Clinical (unspecified phase) |
0.6746 |
Remote Similarity |
NPD4074 |
Clinical (unspecified phase) |
0.6719 |
Remote Similarity |
NPD2877 |
Clinical (unspecified phase) |
0.6719 |
Remote Similarity |
NPD2876 |
Phase 3 |
0.6688 |
Remote Similarity |
NPD9484 |
Clinical (unspecified phase) |
0.6687 |
Remote Similarity |
NPD1730 |
Discontinued |
0.6685 |
Remote Similarity |
NPD4054 |
Clinical (unspecified phase) |
0.6649 |
Remote Similarity |
NPD2824 |
Phase 2 |
0.6626 |
Remote Similarity |
NPD171 |
Discontinued |
0.6624 |
Remote Similarity |
NPD1058 |
Discontinued |
0.6599 |
Remote Similarity |
NPD9374 |
Approved |
0.6575 |
Remote Similarity |
NPD9373 |
Approved |
0.6564 |
Remote Similarity |
NPD4240 |
Approved |
0.6545 |
Remote Similarity |
NPD7531 |
Clinical (unspecified phase) |
0.6543 |
Remote Similarity |
NPD1431 |
Approved |
0.6543 |
Remote Similarity |
NPD1430 |
Approved |
0.6536 |
Remote Similarity |
NPD9084 |
Phase 2 |
0.6533 |
Remote Similarity |
NPD307 |
Approved |
0.651 |
Remote Similarity |
NPD4458 |
Phase 2 |
0.651 |
Remote Similarity |
NPD4459 |
Clinical (unspecified phase) |
0.6494 |
Remote Similarity |
NPD527 |
Clinical (unspecified phase) |
0.6464 |
Remote Similarity |
NPD1046 |
Clinical (unspecified phase) |
0.645 |
Remote Similarity |
NPD9605 |
Phase 3 |
0.6433 |
Remote Similarity |
NPD8829 |
Clinical (unspecified phase) |
0.6432 |
Remote Similarity |
NPD2903 |
Clinical (unspecified phase) |
0.6432 |
Remote Similarity |
NPD2902 |
Phase 2 |
0.6415 |
Remote Similarity |
NPD9083 |
Clinical (unspecified phase) |
0.6392 |
Remote Similarity |
NPD282 |
Approved |
0.6375 |
Remote Similarity |
NPD1119 |
Phase 2 |
0.6364 |
Remote Similarity |
NPD2152 |
Clinical (unspecified phase) |
0.6364 |
Remote Similarity |
NPD798 |
Discontinued |
0.6364 |
Remote Similarity |
NPD9704 |
Approved |
0.6319 |
Remote Similarity |
NPD8836 |
Approved |
0.6267 |
Remote Similarity |
NPD9584 |
Phase 2 |
0.6258 |
Remote Similarity |
NPD1808 |
Phase 1 |
0.6258 |
Remote Similarity |
NPD799 |
Phase 1 |
0.6257 |
Remote Similarity |
NPD1063 |
Phase 2 |
0.625 |
Remote Similarity |
NPD545 |
Clinical (unspecified phase) |
0.625 |
Remote Similarity |
NPD547 |
Clinical (unspecified phase) |
0.6235 |
Remote Similarity |
NPD1121 |
Approved |
0.6235 |
Remote Similarity |
NPD1120 |
Approved |
0.6213 |
Remote Similarity |
NPD775 |
Approved |
0.6203 |
Remote Similarity |
NPD1127 |
Approved |
0.6203 |
Remote Similarity |
NPD1128 |
Approved |
0.6199 |
Remote Similarity |
NPD353 |
Discontinued |
0.6184 |
Remote Similarity |
NPD8831 |
Approved |
0.6184 |
Remote Similarity |
NPD8833 |
Approved |
0.6178 |
Remote Similarity |
NPD281 |
Approved |
0.6158 |
Remote Similarity |
NPD2593 |
Clinical (unspecified phase) |
0.615 |
Remote Similarity |
NPD5627 |
Approved |
0.6145 |
Remote Similarity |
NPD2253 |
Discontinued |
0.6142 |
Remote Similarity |
NPD5486 |
Discontinued |
0.6122 |
Remote Similarity |
NPD1816 |
Clinical (unspecified phase) |
0.6098 |
Remote Similarity |
NPD6112 |
Approved |
0.6084 |
Remote Similarity |
NPD1118 |
Discontinued |
0.6081 |
Remote Similarity |
NPD5171 |
Clinical (unspecified phase) |
0.6068 |
Remote Similarity |
NPD5080 |
Phase 2 |
0.6067 |
Remote Similarity |
NPD9375 |
Discontinued |
0.6065 |
Remote Similarity |
NPD9409 |
Discontinued |
0.605 |
Remote Similarity |
NPD5458 |
Discontinued |
0.6029 |
Remote Similarity |
NPD6381 |
Phase 2 |
0.6019 |
Remote Similarity |
NPD5079 |
Phase 2 |
0.5978 |
Remote Similarity |
NPD5768 |
Phase 2 |
0.5945 |
Remote Similarity |
NPD7502 |
Clinical (unspecified phase) |
0.5939 |
Remote Similarity |
NPD535 |
Approved |
0.5938 |
Remote Similarity |
NPD515 |
Phase 1 |
0.592 |
Remote Similarity |
NPD7842 |
Phase 2 |
0.5917 |
Remote Similarity |
NPD1117 |
Clinical (unspecified phase) |
0.5886 |
Remote Similarity |
NPD8830 |
Phase 3 |
0.5878 |
Remote Similarity |
NPD9626 |
Clinical (unspecified phase) |
0.5876 |
Remote Similarity |
NPD1017 |
Clinical (unspecified phase) |
0.5872 |
Remote Similarity |
NPD6840 |
Approved |
0.5856 |
Remote Similarity |
NPD1122 |
Clinical (unspecified phase) |
0.5833 |
Remote Similarity |
NPD9360 |
Approved |
0.5811 |
Remote Similarity |
NPD341 |
Approved |
0.5811 |
Remote Similarity |
NPD340 |
Approved |
0.5802 |
Remote Similarity |
NPD1354 |
Approved |
0.5802 |
Remote Similarity |
NPD1356 |
Approved |
0.5802 |
Remote Similarity |
NPD1355 |
Clinical (unspecified phase) |
0.5787 |
Remote Similarity |
NPD6023 |
Discontinued |
0.5784 |
Remote Similarity |
NPD796 |
Phase 2 |
0.5769 |
Remote Similarity |
NPD1368 |
Approved |
0.5752 |
Remote Similarity |
NPD8250 |
Phase 2 |
0.5742 |
Remote Similarity |
NPD757 |
Phase 3 |
0.5741 |
Remote Similarity |
NPD1775 |
Approved |
0.5741 |
Remote Similarity |
NPD9696 |
Approved |
0.5741 |
Remote Similarity |
NPD1085 |
Approved |
0.5723 |
Remote Similarity |
NPD2221 |
Clinical (unspecified phase) |
0.5714 |
Remote Similarity |
NPD9544 |
Approved |
0.5714 |
Remote Similarity |
NPD78 |
Approved |
0.5708 |
Remote Similarity |
NPD4555 |
Clinical (unspecified phase) |
0.567 |
Remote Similarity |
NPD3913 |
Clinical (unspecified phase) |
0.5648 |
Remote Similarity |
NPD2456 |
Phase 2 |
0.5648 |
Remote Similarity |
NPD2457 |
Phase 2 |
0.5637 |
Remote Similarity |
NPD4713 |
Clinical (unspecified phase) |
0.5637 |
Remote Similarity |
NPD4714 |
Approved |
0.5637 |
Remote Similarity |
NPD34 |
Approved |
0.5637 |
Remote Similarity |
NPD4715 |
Clinical (unspecified phase) |
0.5633 |
Remote Similarity |
NPD237 |
Clinical (unspecified phase) |
0.5633 |
Remote Similarity |
NPD578 |
Discontinued |
0.5629 |
Remote Similarity |
NPD9291 |
Approved |
0.5617 |
Remote Similarity |
NPD579 |
Clinical (unspecified phase) |
0.5608 |
Remote Similarity |
NPD3108 |
Clinical (unspecified phase) |
0.5607 |
Remote Similarity |
NPD5342 |
Clinical (unspecified phase) |
0.56
|
Remote Similarity |
NPD8837 |
Clinical (unspecified phase) |